Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

80 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Association between prostaglandin E receptor subtype EP4 overexpression and unstable phenotype in atherosclerotic plaques in human.
Cipollone F, Fazia ML, Iezzi A, Cuccurullo C, De Cesare D, Ucchino S, Spigonardo F, Marchetti A, Buttitta F, Paloscia L, Mascellanti M, Cuccurullo F, Mezzetti A. Cipollone F, et al. Among authors: fazia ml. Arterioscler Thromb Vasc Biol. 2005 Sep;25(9):1925-31. doi: 10.1161/01.ATV.0000177814.41505.41. Epub 2005 Jul 14. Arterioscler Thromb Vasc Biol. 2005. PMID: 16020747
The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control.
Cipollone F, Iezzi A, Fazia M, Zucchelli M, Pini B, Cuccurullo C, De Cesare D, De Blasis G, Muraro R, Bei R, Chiarelli F, Schmidt AM, Cuccurullo F, Mezzetti A. Cipollone F, et al. Among authors: fazia m. Circulation. 2003 Sep 2;108(9):1070-7. doi: 10.1161/01.CIR.0000086014.80477.0D. Epub 2003 Aug 11. Circulation. 2003. PMID: 12912808
Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteinase activity.
Cipollone F, Fazia M, Iezzi A, Pini B, Cuccurullo C, Zucchelli M, de Cesare D, Ucchino S, Spigonardo F, De Luca M, Muraro R, Bei R, Bucci M, Cuccurullo F, Mezzetti A. Cipollone F, et al. Among authors: fazia m. Circulation. 2004 Mar 30;109(12):1482-8. doi: 10.1161/01.CIR.0000121735.52471.AC. Epub 2004 Mar 22. Circulation. 2004. PMID: 15037537 Clinical Trial.
Association between 5-lipoxygenase expression and plaque instability in humans.
Cipollone F, Mezzetti A, Fazia ML, Cuccurullo C, Iezzi A, Ucchino S, Spigonardo F, Bucci M, Cuccurullo F, Prescott SM, Stafforini DM. Cipollone F, et al. Among authors: fazia ml. Arterioscler Thromb Vasc Biol. 2005 Aug;25(8):1665-70. doi: 10.1161/01.ATV.0000172632.96987.2d. Epub 2005 Jun 2. Arterioscler Thromb Vasc Biol. 2005. PMID: 15933245
COX-2 and atherosclerosis.
Cipollone F, Fazia ML. Cipollone F, et al. J Cardiovasc Pharmacol. 2006;47 Suppl 1:S26-36. doi: 10.1097/00005344-200605001-00006. J Cardiovasc Pharmacol. 2006. PMID: 16785826 Review.
Suppression of RAGE as a basis of simvastatin-dependent plaque stabilization in type 2 diabetes.
Cuccurullo C, Iezzi A, Fazia ML, De Cesare D, Di Francesco A, Muraro R, Bei R, Ucchino S, Spigonardo F, Chiarelli F, Schmidt AM, Cuccurullo F, Mezzetti A, Cipollone F. Cuccurullo C, et al. Arterioscler Thromb Vasc Biol. 2006 Dec;26(12):2716-23. doi: 10.1161/01.ATV.0000249630.02085.12. Epub 2006 Oct 12. Arterioscler Thromb Vasc Biol. 2006. PMID: 17038636 Clinical Trial.
80 results